Prevalence of Extended Spectrum Betalactamase (ESBL)‎ and Metallobetalactamase (MBL)‎ Producing Pseudomonas aeruginosa and Acinetobacter baumannii Isolated from Various Clinical Samples

Abstract EN

This study was conducted with an objective to find the prevalence of extended spectrum betalactamase (ESBL) and metallobetalactamase (MBL) in P.

aeruginosa and A.

baumannii isolates obtained from various clinical samples.

It was conducted in the Department of Microbiology, Adesh Institute of Medical Sciences and Research, Bathinda, over a period of two years from July 2014 to June 2016.

Clinical specimens including urine, pus, blood, high vaginal swabs, respiratory samples, and various body fluids were processed and P.

aeruginosa and A.

baumannii isolates were identified by standard protocols.

Antibiotic sensitivity testing for all isolates was done using Kirby-Bauer disc diffusion method.

Disc potentiation test was performed to check ESBL and MBL production in these bacteria.

Maximum ESBL positive isolates of P.

aeruginosa were observed among pus samples and maximum MBL positive isolates were detected in tracheal aspirates.

A.

baumannii showed maximum positivity for ESBL and MBL production in endotracheal secretions.

This study gives an alarming sign towards high prevalence of cephalosporin and carbapenem resistance due to production of extended spectrum betalactamases and metallobetalactamases, respectively.

Early detection, stringent antibiotic policies, and compliance towards infection control practices are the best defenses against these organisms.